Clinical Trial Update: Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Pfizer-sponsored Phase 1/2 study evaluating AG-013736 with chemotherapy and bevacizumab in metastatic colorectal cancer has completed, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• AG-013736
• Bevacizumab (bevacizumab)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Pfizer | Conditions: Colorectal Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-06-04